Advancis Pharmaceutical is now MiddleBrook™ Pharmaceuticals, Inc.

In 2000, MiddleBrook Pharmaceuticals, Inc. made a novel discovery. Bacteria exposed to antibiotics in front-loaded, sequential bursts, or pulses, are killed more efficiently than those exposed to standard antibiotic treatment regimens.

Today, we are working to develop and commercialize pulsatile drug products, applying our patented finding to create a new outlook on anti-infective therapy.
+ Learn more.

Aug 14, 2008
MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
+ more info

Jul 30, 2008
MiddleBrook Pharmaceuticals Files Definitive Proxy Statement with Respect to Proposed $100 Million Investment from EGI
+ more info

Jul 22, 2008
MiddleBrook Pharmaceuticals to Conduct Investor Update Conference Call on July 24, 2008
+ more info